BOW vs INCY · P/E 16, rev $551.6M vs P/E 14, rev $5.14B
Bowhead Specialty Holdings Inc. (BOW) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Bowhead Specialty Holdings Inc. (BOW) is a insurance - property & casualty company listed on NYSE.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported BOW revenue for 2025-12-31 was $551.6M. Net income was $53.8M. Revenue was up 29.6% from 2024-12-31 to 2025-12-31. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
BOW currently screens at market cap $903.7M and trailing P/E 15.9. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the BOW and INCY stock pages for the full models.
Not investment advice.